Your browser doesn't support javascript.
loading
SETD2 histone modifier loss in aggressive GI stromal tumours.
Huang, Kie Kyon; McPherson, John R; Tay, Su Ting; Das, Kakoli; Tan, Iain Beehuat; Ng, Cedric Chuan Young; Chia, Na-Yu; Zhang, Shen Li; Myint, Swe Swe; Hu, Longyu; Rajasegaran, Vikneswari; Huang, Dachuan; Loh, Jia Liang; Gan, Anna; Sairi, Alisa Noor Hidayah; Sam, Xin Xiu; Dominguez, Lourdes Trinidad; Lee, Minghui; Soo, Khee Chee; Ooi, London Lucien Peng Jin; Ong, Hock Soo; Chung, Alexander; Chow, Pierce Kah-Hoe; Wong, Wai Keong; Selvarajan, Sathiyamoorthy; Ong, Choon Kiat; Lim, Kiat Hon; Nandi, Tannistha; Rozen, Steve; Teh, Bin Tean; Quek, Richard; Tan, Patrick.
Affiliation
  • Huang KK; Cancer Science Institute of Singapore, National University of Singapore, Center for Translational Medicine, Singapore, Singapore.
  • McPherson JR; Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Tay ST; Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Das K; Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Tan IB; Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Ng CC; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Chia NY; Genome Institute of Singapore, Singapore, Singapore.
  • Zhang SL; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Myint SS; Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Hu L; Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Rajasegaran V; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Huang D; Cancer Science Institute of Singapore, National University of Singapore, Center for Translational Medicine, Singapore, Singapore.
  • Loh JL; Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Gan A; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Sairi AN; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Sam XX; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Dominguez LT; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Lee M; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Soo KC; Department of Pathology, Singapore General Hospital, 11 Hospital Drive, Singapore, Singapore.
  • Ooi LL; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Ong HS; Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Chung A; Division of Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Chow PK; Department of Hepatopancreaticobiliary & Transplant Surgery, Singapore General Hospital, Singapore, Singapore.
  • Wong WK; Department of Upper GI & Bariatric Surgery, Singapore General Hospital, Singapore, Singapore.
  • Selvarajan S; Department of Hepatopancreaticobiliary & Transplant Surgery, Singapore General Hospital, Singapore, Singapore.
  • Ong CK; Division of Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Lim KH; Office of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Nandi T; Program in Translational and Clinical Liver Research, National Cancer Center Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Rozen S; Department of Upper GI & Bariatric Surgery, Singapore General Hospital, Singapore, Singapore.
  • Teh BT; Department of Pathology, Singapore General Hospital, 11 Hospital Drive, Singapore, Singapore.
  • Quek R; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, Singapore.
  • Tan P; Department of Pathology, Singapore General Hospital, 11 Hospital Drive, Singapore, Singapore.
Gut ; 65(12): 1960-1972, 2016 12.
Article in En | MEDLINE | ID: mdl-26338826
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Histone-Lysine N-Methyltransferase / Mutation, Missense / Gastrointestinal Stromal Tumors Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Gut Year: 2016 Document type: Article Affiliation country: Singapur Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Histone-Lysine N-Methyltransferase / Mutation, Missense / Gastrointestinal Stromal Tumors Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Gut Year: 2016 Document type: Article Affiliation country: Singapur Country of publication: Reino Unido